List of Posts

 

Date Title Topic
1/3/14 Bad Air Malaria product devlment
12/27/13 Rea View Mirror Update
12/19/13 Pictures at an Exhibition Take two People in global health
12/12/13 Shameless Plug ND medchem data portal
12/5/13 WIPO Wipeout Update on Re:Search
11/28/13 (Not So) Wayback Machine Update of past posts
11/21/13 One Trillion Plus Global med market
11/14/13 Better than Expected GSK’s DPAc update
11/7/13 Rxs for Vxs Gates vaccine efforts
10/31/13 Halloweenie T1D Innovations
10/24/13 Throwing Darts Drug sales forecasting
10/17/13 Trickle Down MNCs in ROW markets
10/10/13 Under the Radar Nanobiosym
10/3/13 Tossed from the Balcony GH Investment Fund
9/26/13 The Price is Right Drug pricing
9/19/13 Off on the Right Foot Incorporation
9/12/13 RTPCR for All RTPCR diagnostics
9/5/13 Bio-simulation Biosimilars update
8/29/13 Rockin’ the Dx Update Alere, QuantuMDx
8/22/13 More not Less Gates’s investments
8/15/13 Uni-versal Medtech, Gradian revisit
8/8/13 From Bad to Worse Indian drug market
8/1/13 Vakzine Projekt TB vaccine, VPM1002
7/25/13 Still Neglected Sickle Cell Disease drugs
7/18/13 Mundo Sano Cancer vax Vaxira
7/11/13 Procurement Power Brazilian MOH program
7/4/13 Soup to Nuts Epirus start-up
6/27/13 Model or Muddle? Emory DRIVE
6/20/13 The Good, the Bad, and the Ugly GSK DPAc program
6/13/13 Vax Tech SE
6/6/13 Middleman Intl pharma distribution
5/30/13 GHIT Ready Japanese GH fund
5/23/13 From Treat to Treat (Reprise) SE
5/16/13 More Toes in the Water Takeda, Inviragen buy
5/9/13 GSK Splashes Away GSK, drug development
5/2/13 Tech Transfer for the Rest of the World SE
4/25/13 Health Care for All Universal HC coverage
4/18/13 A Rare Request, an Orphan Offer Rare drug development
4/11/13 Reality Check Manish Bhardwaj, IIH
4/4/13 Victory! Gleevec case
3/28/13 VC Vacuum VC in BRICS
3/21/13 Nuts and Bolts Lite MIT start-up course
3/14/13 Headed East China medtech
3/7/13 Dx Rock Stars Alere, QuantuMDx
2/28/13 Knick-Knacks GH cos., PaxVax
2/21/13 Indian Kathi Indian medtech
2/14/13 Medical Walmartinization NH hospitals of India
2/7/13 Building with BRICS BRICS GH innovation
1/31/13 Accelo-rama Startup accelerators
1/24/13 BVGH:  RIP or Reboot BVGH
1/17/13 Nothing Ventured Gates PRI
1/10/13 More Fun and Profit Biotech models
1/3/13 For Fun and Profit R4D report on GHSEs
12/27/12 Ringing in Another Year (also in My Ears) 2012 posts
12/20/12 Walk the Talk USAID, MIT tech devel
12/13/12 Crossing My Desk Again Pharma, drugs, IFC
12/6/12 The NCD Target NCD product development
11/29/12 A Free Lunch GH investment fund
11/22/12 Downsize or Downhill? BVGH
11/15/12 Vax Patch Vaccine delivery startup
11/8/12 Gadgets and Gizmos for Dx Dx co. start up
11/1/12 Trick not Treat Medicine quality
10/25/12 Mix and Match TB drug market
10/18/12 Drug of Choice TB drug development
10/11/12 Universal Medtech, UAM
10/4/12 Mega-fun R and D funding
9/27/12 Dueling Sitars Indian govt and MNCs
9/20/21 Innovate or Go Away Delivery innovations
9/13/12 Counter Counterfeiting Anti-counterfeiting
9/6/12 Virtual Reality Biotech Reprise SE
8/30/12 Rolling the Dice HCV start-up co.
8/23/12 Missing the Boat from the Other Direction ROW innovation
8/16/12 Down at the A&P Novartis’s AP program
8/9/12 Playing the Long Game ROW markets
8/2/12 To Boldly Go ROW medtech
7/26/12 Out in Left Field Again SE
7/19/12 Too Big to Flail Recycled PATH, OneWorld Health
7/12/12 A Toe in the Water BMGF PRI program
7/5/12 Bottleneckrophobia Intl registration
6/28/12 See Change BIO 2012
6/21/12 BIO Bits BIO 2012
6/14/12 Out in Left Field Therapeutic TB vax
6/7/12 A Bumper Crop Startup programs
5/31/12 New and Improved! Medtech in India
5/24/12 Discount Drugs Biosimilars
5/17/12 Tech Talk RDT diagnostics
5/10/12 More Bang for the Buck Pooled procurement
5/3/12 It’s NIGH Time GHTC report on prod dev
4/26/12 Climatic Change-Up Dengue vaccine
4/19/12 Boot Straps Essential health plans
4/12/12 MONGO Bingo GH startups
4/5/12 BD Needy BVGH report
3/29/12 Virtual Reality Biotech Dual market startups
3/22/12 Crossing My Desk Newsy items
3/15/12 A Tale of Two Companies MEND and Breathable Foods
3/8/12 On the Drawing Board TB Dx
3/1/12 TB Dx:  Getting There TB Dx
2/23/12 Hunting the Elusive Snark BIO panel, public sector
2/16/12 Orphaned and Neglected Orphan Drug Act
2/9/12 Putting the Biz into BoP BoP pharma report
2/2/12 NTD TD NTD effort
1/26/12 The Three-Point Shot Vaccine deals
1/19/12 A Better World? AUTM report
1/12/12 PATH Finding PATH, impact measurement
1/5/12 Too Big to Flail OWH takeover
12/29/11 More Grease for the COGs Biomanufacturing
12/22/11 Ringing in the New Year (and in My Head) Vaccines
12/15/11 Innovate or Die ROW healthcare
12/8/11 No Kiddin’ Pediatric GH
12/1/11 PET Friendly Rabies vaccine franchise
11/25/11 Revenge of the Microbes II EU AMR program
11/18/11 A Long Strange Trip Malaria drug development
11/10/11 Verify Then Trust Data, PDPs
11/3/11 Window Dressing WIPO ReSearch, BVGH
10/27/11 Made in China China, ROW markets
10/20/11 Not So NICE Pharma model
10/13/11 Beyond the Band-Aid SMEs, new GH group
10/6/11 Free Advice, Trevor New Gates guy
9/29/11 Drug Bust US market
9/22/11 Biosimilar Fever Biosimilar market
9/15/11 Generics Play Generics and Cipla
9/8/11 Market Failure Cancer drug shortage
9/1/11 Gone Fishin’ Cheaper DD/NuMedii
8/25/11 A Better Type of Prize Lem-MIT prize
8/18/11 Missing the Boat ROW markets
8/11/11 mmmmHeatlh Health hotlines
8/4/11 S and M Sales intermediates
7/28/11 A Quiet Week at Lake Woebegone DAT, UNITAID, MenAfriVac
7/21/11 Eyes on the Prize Epistem TB Dx
7/14/11 USAID:  Rhetoric or Reality? Tech devel support
7/7/11 Backyard Biotech Virtual biotech model
6/30/11 Over to the Dark Side Yamada’s new job
6/23/11 Thinking Out of the Box Reprise SE
6/16/11 Healthy, Wealthy, and Wise Reprise SE
6/9/11 A Pleasant Surprise Reprise SE
6/2/11 USAID and Innovation Reprise SE
5/26/11 Checking the Pool’s Temperature BVGH IP pool
5/19/11 Micro Need Macro Problem IDD and IBET
5/12/11 This Little Piggy ROW healthcare
5/5/11 Nuts and Bolts BVGH Forum
4/28/11 Skin in the Game CFFT, PDP BD
4/21/11 Revenge of the Microbes Drug-resistance
4/14/11 BMGF Ventures LLP BMGF Liquidia PRI
4/7/11 B2B2B2B HIGH Dx mtg
3/31/11 TB DD Needy TB pipeline
3/24/11 Deal of the Year 2011 Biocon/Pfizer deal
3/17/11 Bits and Byes from the Info-stream DD cost, euSEND, BVGH
3/10/11 Creditworthy Tax credits
3/3/11 Open Source Sesame OS for NG DD
2/24/11 Brother, Can You Spare a Dime (or Five)? NTD treatment
2/17/11 Slicing the Baloney DD by academia
2/10/11 Greasing the COGs Vax manu
2/3/11 Bugs in the Ointment Malaria vax
1/27/11 Starting Uphill Nonex licensing
1/20/11 A Plan for Essential Care SWAps and EHPs
1/13/11 ReDuX Part II Diagnostics
1/6/11 ReDuX Diagnostics
12/29/10 A Shot in the Arm Vaccines in 2011
12/23/10 Kvetching Review of posts
12/16/10 Watch Out Big Pharma? Meng Vac Progm
12/9/10 Yet Another R4D Institute
12/2/10 AIDS Aid (Maybe) Ditto
11/28/10 Thanksgiving HIV thera vaccine
11/18/10 Thanks but No Thanks MGH GH Ctr Symp
11/11/10 Pharma, Reinvent Thyself SE
11/4/10 Drug Development on the Cheap SE
10/28/10 Affordability Revisited Health care delivery
10/21/10 Start Up Mode Networking, GATE
10/14/10 Affordability Health insurance
10/7/10 Holy Grail Horse Race Dry powder vaccines
9/30/10 Smart Money Industry drug devel
9/23/10 Healthy, Wealthy, and Wise ROW companies
9/16/10 Mending the Gap MTHG meeting
9/7/10 Market Tested and Not-yet Approved Hlth Mrkt Innovs
9/2/10 Singin’ Be-BOP App technology
8/26/10 Beached Update on posts
8/19/10 Mid-August Meander More reflection
8/12/10 Patents Persona Non Grata Big pharma patents
8/5/10 Knickers in a Twist Unitaid patent pool
7/29/10 A Really Neglected Disease Sickle cell disease
7/22/10 I’d Love to Change the World Cash transfer prgms
7/15/10 Fio Cruise ROW and Fiocruz
7/9/10 A Day Late and Many Dollars Short NIH trials fund
7/1/10 News Flash from Puzzler Tower GH sites
6/24/10 Una Sorpresa Prometedora Archivel TB vaccine
6/17/10 The Emperor’s New Clothes Com Cap and IOWH
6/10/10 AMFm: Not Your Ordinary Radio AMFm
6/3/10 Access to Medicines/Access to Markets CHAI DAT strategy
5/27/10 Commercialization:  a Going Concern SE
5/20/10 MedTech Made Easy BU Medtech meeting
5/13/10 Thinking Out of the Box Dx
5/6/10 BIO Break More reflection
4/29/10 Moving Along Smartly Smart GH comm.
4/22/10 Medical Diplomacy:  a Ship of State Adrift SE
4/15/10 Too Much Alarm (and Not Enough Cow) Bell Globe article on HIV
4/8/10 DIY Vaccines SE
4/1/10 USAID and Innovation SE
3/25/10 A New Deal Against TB Crit Path Inst
3/18/10 Pictures in an Exhibition Reflection on life
3/11/10 Accelerated POC SE
3/4/10 Exertion Toward a Common Object Networking
2/25/10 Where Does This PATH Lead? SE
2/18/10 Watering the Grass Social venturing
2/11/10 PDP Performance Measurement SE
2/4/10 Official US Government Global Health Program SE
1/28/10 GSK in the Lead but Who Will Follow SE
1/21/10 Creating the Upside IFFI
1/14/10 PRIs for Global Health SE
1/7/10 Lifting the Burden Intl development
12/17/09 SEAMs Right MSH pharmacies
12/10/09 Technology Fix or Fixation? PATH vvms
12/3/09 Peloton Partnering:  A Friend for FRIND SE
11/24/09 Gates Foundation:  For-Profits Need Not Apply? SE
11/12/09 An Academic Approach to Global Health AUTM lic prins
11/5/09 The SBIR Drop in the Bucket SE
10/28/09 A Holy Grail Aktiv-Dry vaccine
10/20/09 Heads Up, Pharma Emerging markets
10/13/09 Is there a Bottom Line behind the Headline? Hilleman Labs
10/5/09 Swimming in the Patent Pool GSK patent pool
9/27/09 Converting Inspiration to Investment BVGH case studies
9/22/09 BVGH: at a Critical Junction? BVGH
9/15/09 Generic Open License Revisited Licensing scheme

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s